Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire•30/09/2026•16:30 ET
0
Key Highlights
- ➤Sarepta Therapeutics (SRPT) granted 211,070 restricted stock units to 37 third-quarter hires
- ➤RSUs vest one-fourth annually, fully vesting on each employee’s fourth anniversary
- ➤Employees received no options to purchase Sarepta common stock
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on Sept. 30, 2026 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2024 Employment Commencement Incentive Plan, as a material inducement to employment to 37 individuals hired by Sarepta in the third quarter of 2026. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
Get started
Create a free account to read the full story.